Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03671993
Other study ID # ShanghaiIAMM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 5, 2018
Est. completion date March 10, 2019

Study information

Verified date September 2018
Source Shanghai Institute of Acupuncture, Moxibustion and Meridian
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this randomized controlled trial, we intend to determine whether electrical pudendal nerve stimulation is more effective than intravesical instillation in urethral pain syndrome.


Description:

According to the 2017 edition of European Association of Urology Guideline, there is no specific treatment for urethral pain syndrome (UPS), and it is recommended this type of patients should be treated in a multi-disciplinary and multi-modal program. Since some mechanisms for the development of UPS suggest it may be a form of bladder pain syndrome (BPS) due to the intimate relation of the urethra with the bladder (both covered with urothelium), a combination of intravesical hyaluronic acid and lidocaine plus sodium bicarbonate, the more widely used regimen for BPS in China, is also applied to UPS here in China. However, the symptom relief of the intravesical irrigation won't last long and patients usually report recurrence in 2-3 weeks. Hence, the purpose of this study is to explore whether the electrical pudendal nerve stimulation(EPNS), which has been proven effective in treating BPS, is more effective than intravesical instillation (intravesical hyaluronic acid and lidocaine plus sodium bicarbonate) in patients with UPS.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 10, 2019
Est. primary completion date February 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

1. male or female patients aged 18 - 75

2. Occurrence of chronic or recurrent episodic pain perceived in the urethra, especially related to micturition, for more than 3 months; accompanied by other symptoms such as increased daytime and night-time frequency, in the absence of proven infection or other obvious urethral pathology such as urethral diverticulum.

3. Negative in urine routine test or urine cultivation.

4. agreement to sign the written informed consent.

Exclusion Criteria:

1. Symptoms relieved by anti-inflammatory drugs, a-blockers, muscle relaxants.

2. A diagnosis of bacterial cystitis or prostatitis within a 3-month period; bladder or ureteral calculi; active genital herpes; any type of cystitis; vaginitis.

3. life threatening complication such as uterine, cervical, vaginal, or urethral cancer, bladder tumor, heart failure, cardiovascular disease, hemorrhagic disease, uncontrolled diabetes, and/or factors that can affect hemostasis.

4. Female patients with pregnancy or lactation.

5. Serious mental disorders.

Study Design


Intervention

Procedure:
Electrical pudendal nerve stimulation
Four sacrococcygeal points were selected. Two 0.40?100 mm needles were inserted perpendicularly to a depth of 80-90 mm 1 cm bilateral to the sacrococcygeal joint, to produce a sensation referred to the root of the penis (perineum) or the anus. Two needles of 0.40?100 or 125mm were inserted obliquely toward the ischiorectal fossa to a depth of 90 to 110 mm about 1 cm bilateral to the tip of the coccyx, to produce a sensation referred to the root of the penis (or the perineum). Each two ipsilaterally needles were connected to one electrode from a G6805-2Multi-Purpose Health Device (Shanghai Medical Instruments High-Techno, Shanghai, China), with a frequency of 2.5 Hz and an intensity (45~55 mA). EPNS was given for 60 min a time, 3 sessions per week for 6 weeks.
Intravesical instillation
The patient should lie on a couch in a lithotomy position after urination. A catheter was passed through the urethra into the bladder and any residual urine should be drained. A mixture of the Cystistat (sodium hyaluronate, 50ml 40mg, Bioniche Teoranta, Ireland) solution and Lidocaine hydrochloride (40mg :20ml, Fangming Pharmacy company, Shangdong, China) is instilled through the catheter into the bladder. The catheter is then withdrawn leaving the mixture solution inside the bladder, retained for as long as possible, ideally at least 30 minutes. The instillation is once weekly for at 6 weeks.

Locations

Country Name City State
China Shanghai research institute of acupuncture and meridian Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Institute of Acupuncture, Moxibustion and Meridian

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pelvic Pain, Urgency and Frequency Questionnaire ( PUF questionnaire) This instrument consists of eight items that cover areas of pain, urgency, urinary frequency, and symptoms associated with sexual intercourse. The score ranges from 0 to 35 points. Each participant will be evaluated by using the PUF at baseline, three weeks after the treatment commencement and six weeks after the treatment commencement, and we are about to record the mean change of the overall score of this questionnaire. 6 weeks
Secondary Visual Analogue Scale for pain Participants will be asked to mark the degree of pain in urethral on a 10-mm VAS, with "0" indicating no pain and "10" indicating the worst painimaginable. Each participant will be evaluated by using this instrument at baseline, three weeks after the treatment commencement and six weeks after the treatment commencement, and we are about to record the mean change of the score. 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05344716 - FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women N/A
Not yet recruiting NCT03252041 - MRI & MRV in Pelvic Congestion Syndrome in Females N/A
Completed NCT03715777 - Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain Phase 3
Withdrawn NCT04046406 - Pelvic Pain Treated With MR-guided Cryoanalgesia N/A
Recruiting NCT06124664 - Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
Not yet recruiting NCT03943381 - Duplex US in Pelvic Congestion Syndrome in Females (PCS)
Completed NCT03797911 - Efficacy of Resistive Capacitive Monopolar Radiofrequency in the Physiotherapeutic Treatment of Chronic Pelvic Pain: RCT N/A
Not yet recruiting NCT06168058 - Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices N/A
Recruiting NCT05489133 - Early Psychological Intervention After Rape N/A
Not yet recruiting NCT04910672 - Primary Dysmenorrhea and Osteopathic Treatment N/A
Completed NCT04135118 - Validation of the Adenomyosis Calculator
Recruiting NCT06102733 - Chronic Pelvic Pain in Females and Males
Recruiting NCT06369545 - Chronic Pelvic Pain Syndrome in Males N/A
Enrolling by invitation NCT05513417 - Digital Care Programs for Female Pelvic Health
Completed NCT06080828 - Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women N/A